Skip to main content
Caplight Logo









KeyReply

KeyReply

Private
SingaporeHealthcare & Life Scienceshttps://www.keyreply.com/

Last Round

Early Funding

Feb 24, 2025

Total Funding Raised

$25,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

KeyReply is a software company that develops an enterprise conversational AI and AI orchestration platform designed to automate patient and employee experiences with a focus on the healthcare sector.

Sector

Healthcare & Life Sciences

Verticals

NLP & Conversational AI, Patient Engagement, Medical AI, Workflow Automation, EHR & EMR

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts, Usage-Based SaaS

AI Layer

Application

Keywords

AI orchestration platformhealthcare AImedical AIgenerative AIvirtual assistanthealthcare chatbotpatient engagementworkflow automationagentic AIAI agentlow/no-code platformpatient intakevoice AIappointment schedulingEMR integrationWhatsApp automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KeyReply Comparables

Compare KeyReply with similar companies based on industry and business-model similarity.

KeyReply comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Orbita
86%
Medchat
81%
Mediktor
79%

KeyReply Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingFeb 24, 2025
SeedJun 8, 2016
AcceleratorSep 23, 2015

Key People

Founding team and executive leadership

Max X.

Founder & CTO

Founding Team

Peiru Teo

CEO

Executive Team

KeyReply Investors

Notable investors and investment history

KeyReply investors
InvestorRounds
Hawaii AngelsSeed
AngelPadSeed
Quest VenturesSeed
Blue StartupsAccelerator, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 43, 102% of current headcount.

  • Feb 25, 2026

    Grew 38% QoQ, from 32 to 44 employees.

KeyReply Filings

Explore SEC and related filing metadata, where available.

KeyReply filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about KeyReply's valuation, stock price, and market status.

Is KeyReply a public or private company?

KeyReply is a private company.

What is the current stock price of KeyReply?

KeyReply is a private company with no public stock price. No recent secondary market data is available.

How much is KeyReply worth (valuation)?

Valuation information for KeyReply is not publicly available.

Can I buy KeyReply stock?

KeyReply shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was KeyReply's last funding round?

KeyReply's most recent funding round was Early Funding on February 24, 2025.

Who are the main investors in KeyReply?

Key investors in KeyReply include Hawaii Angels, AngelPad, Quest Ventures, Blue Startups.

Will KeyReply IPO soon?

No public IPO plans have been announced for KeyReply.

How can I track KeyReply secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KeyReply's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range15
Year Founded2014
Last FundingFeb 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?